In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Sobered Abbott Buys i-Stat

Executive Summary

Abbott Laboratories' acquisition of i-Stat for $392 million reflects the promise and limitations of point-of-care diagnostics. A decade ago, i-Stat was a giddy startup, on a mission to revolutionize laboratory medicine with a handheld diagnostics system that could run basic blood tests rapidly at the patients' bedside. While it has accomplished much, it is far from creating a revolution. Meanwhile, the timing of the deal comes as Abbott emerges from a four-year nightmare with the FDA in which the FDA forced it to pull many of its important immunoassay tests off the market.
Advertisement

Related Content

GE Grabs the Spotlight in IVD
Hospitals' Hang-Ups With Point-Of-Care Testing
I-Stat's $60 Million Gamble
I-Stat's $60 Million Gamble
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
Sigma Aldrich Bows out of Diagnostics
Sigma Aldrich Bows out of Diagnostics
i-Stat's New Mainstream Partner: Abbott
i-Stat's New Mainstream Partner: Abbott
Point-of-Care Testing in an Era of Laboratory Consolidation

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002213

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel